Fasenra carries labeled warnings and precautions for hypersensitivity reactions (e.g., anaphylaxis, angioedema, urticaria, rash) and parasitic (helminth) infection. The Prescribing Information (PI) advises patients to not abruptly discontinue systemic or inhaled corticosteroids upon initiation of Fasenra the...